| Application no. and date | 06819380.4 (espacenet) (Federated) (European Patent Register), 20061109 | | Patent/reg. no. and date | DK/EP 1948180, 20130313 | | Publication date | 20080730 | | Priority no. and date | EP 05110669, 20051111 | | EP pub. no. and date |
EP 1948180 20080730 | | Effective date | | | Applicant/owner | Boehringer Ingelheim International GmbH, Binger Strasse 173
55216 Ingelheim am Rhein, DE | | Applicant ref. no. | 157346 | | Inventor | SOLCA, Flavio, Gesslgasse 10/6
A-1230 WIEN, AT,
BAUM, Anke, Hoeglmuellergasse 4/8
A-1050 Wien, AT,
STEHLE, Gerd, Jahnstr. 1
89584 Ehingen, DE,
VAN MEEL, Jacobus C., A., Kaerntnergasse 6
A-2340 Moedling, AT,
AMELSBERG, Andree, 471 Dublin Road
Southbury, CT 06488, US | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 31/00 (2006.01) , A61K 31/517 (2006.01) , A61P 35/00 (2006.01) | | Title | Kombinationsbehandling af cancer omfattende EGFR/HER2 inhibitorer | | Int. application no. | EP2006068314 | | Int. publication no. | WO2007054551 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
